Stage IIA
Showing 1 - 25 of >10,000
Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)
Not yet recruiting
- Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
- Nivolumab
- +2 more
- (no location specified)
Aug 10, 2022
Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)
Not yet recruiting
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Atorvastatin
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 27, 2023
NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)
Recruiting
- Non-small Cell Lung Cancer
- +3 more
- Toripalimab
- +2 more
-
Yangzhou, Jiangsu, ChinaPeople's hospital of northern jiangsu
Sep 26, 2023
Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma Trial in Toronto (Robotic Retroperitoneal Lymph Node Dissection
Recruiting
- Lymphadenopathy Retroperitoneal
- Stage II Testicular Seminoma
- Robotic Retroperitoneal Lymph Node Dissection (RPLND)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
May 16, 2022
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Neoadjuvent, PD-1 Inhibitor, Lung Cancer Trial in Xi'an (neoadjuvant PD-1 inhibitor, anlotinib combined with chemo)
Recruiting
- Neoadjuvent
- +4 more
- neoadjuvant PD-1 inhibitor, anlotinib combined with chemotherapy
-
Xi'an, ChinaTangdu Hospital, the Air Force Military University
May 26, 2022
Stage I Breast Cancer, Stage I Colorectal Cancer AJCC v6 and v7, Stage I Prostate Cancer Trial in New Brunswick, Philadelphia
Completed
- Stage I Breast Cancer
- +18 more
- Informational Intervention
- +4 more
-
New Brunswick, New Jersey
- +1 more
Aug 23, 2022
Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma
Recruiting
- Clinical Stage I Cutaneous Melanoma AJCC v8
- +13 more
- Cefazolin
- Resection
-
Houston, TexasM D Anderson Cancer Center
Dec 16, 2022
Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)
Not yet recruiting
- Stage IIIB(N2) Non-small Cell Lung Cancer
- +3 more
- Pembrolizumab 200 mg IV infusion
-
Beijing, Beijing, ChinaPeking University
May 30, 2023
NSCLC Trial in Beijing (Icotinib)
Completed
- Non-small Cell Lung Cancer
-
Beijing, Beijing, ChinaXuanwu Hospital, Capital Medical University
Jan 24, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +16 more
- Anhydrous Enol-oxaloacetate
- Questionnaire Administration
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +23 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 5, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +20 more
- Best Practice
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 5, 2023
Patient-Informed Educational Intervention for Improvement of
Withdrawn
- Stage IB Cervical Cancer FIGO 2018
- +15 more
- Educational Intervention
- Survey Administration
- (no location specified)
Mar 25, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Suspended
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Short-Term Fasting
- Chemotherapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +2 more
- Neurotization Procedure
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 30, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial
Withdrawn
- Anatomic Stage 0 Breast Cancer AJCC v8
- +28 more
- Carbon Dioxide Fractional Laser
- Questionnaire Administration
- (no location specified)
Jan 5, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +21 more
- Behavioral, Psychological or Informational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Patient Navigation
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 21, 2022
Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,
Not yet recruiting
- Pancreatic Cancer, Stage IB
- +3 more
- sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Jan 4, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Enrolling by invitation
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Aromatherapy with Essential Oils and Virtual Reality
-
Portland, OregonOHSU Knight Cancer Institute
Jul 21, 2022